ArticleFrontiers in oncology2024

The clinical outcome of pembrolizumab for patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a single center, real world study in China.

Zongyu Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.